Covered recipient · General Payments record
DAVID MATTHEW SCHWARTZBERG
Allopathic & Osteopathic Physicians Colon & Rectal Surgery
General Payments · PY2019–2024
$25,495.21
- Reported across 56 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $15,435.00 | 3 |
| Travel and Lodging | $1,096.36 | 6 |
| Food and Beverage | $481.02 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ConvaTec Inc. | $16,998.16 | 18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ConvaTec Inc. | $1,260.00 | 05/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1151384447 | CMS |
| ConvaTec Inc. | $466.90 | 06/20/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1151384449 | CMS |
| ConvaTec Inc. | $164.00 | 06/20/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1151384451 | CMS |
| ConvaTec Inc. | $145.55 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151384453 | CMS |
| ConvaTec Inc. | $33.20 | 06/21/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1151384455 | CMS |
| ConvaTec Inc. | $108.00 | 06/21/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1151384457 | CMS |
| ConvaTec Inc. | $136.41 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151384459 | CMS |
| ConvaTec Inc. | $10.05 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151384461 | CMS |
| ConvaTec Inc. | $40.81 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151384463 | CMS |
| ConvaTec Inc. | $22.81 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151384465 | CMS |
| ConvaTec Inc. | $9.98 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151384467 | CMS |
| ConvaTec Inc. | $17.33 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151384469 | CMS |
| ConvaTec Inc. | $46.69 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151384471 | CMS |
| ConvaTec Inc. | $37.17 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151384473 | CMS |
| ConvaTec Inc. | $12,915.00 | 08/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1151384475 | CMS |
| ConvaTec Inc. | $260.63 | 08/02/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1151384477 | CMS |
| ConvaTec Inc. | $63.63 | 08/02/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1151384479 | CMS |
| ConvaTec Inc. | $1,260.00 | 12/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1151384481 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.22 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153409491 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.